In this randomized control trial, the authors investigated whether an automated clinical decision support system affects discontinuation rates of potentially nephrotoxic medications and improves outcomes in patients with AKI.

One of the paper’s authors, Dr. F. Perry Wilson, discusses the study and answers questions about the study.